| Application no. and date | 17183045.8 (espacenet) (Federated) (European Patent Register), 20110428 | | Patent/reg. no. and date | DK/EP 3260128, 20200729 | | Publication date | 20171227 | | Priority no. and date | US 329078 P, 20100428 | | EP pub. no. and date |
EP 3260128 20171227 | | Effective date | | | Applicant/owner | Oncolmmune, Inc., 9430 Key West Avenue, Suite 113
Rockville, MD 20850, US | | Applicant ref. no. | P81204549DK01E | | Inventor | ZHENG, Xincheng, 2411 Meadowridge Court
Ann Arbor, MI 48103, US,
ZHENG, Pan, 502 E Street NE
Washington, DC 20002, US,
WU, Wei, 3316 Banneker Drive, NE
Washington, D.C. 20018, US,
LIU, Yang, 502 E Street NE
Washington, DC 20002, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 19/02 (2006.01) | | Title | Medicinsk anvendelse af opløselig CD24 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
